Litcius/Paper detail

Synthesis, characterization and biological evaluation of pyrazole-based benzene sulfonamides as inhibitors of human carbonic anhydrase II, IX and XII

Tajamul Hussain, Saif Ullah, Salman Alrokayan, Salman Alamery, Arif Ahmed Mohammed, Syeda Abida Ejaz, Mubashir Aziz, Jamshed Iqbal

2023RSC Advances11 citationsDOIOpen Access PDF

Abstract

concentration of 0.12 ± 0.07 μM. In addition, compounds 4e and 4k were screened as the preferential inhibitors of the isoform hCAXII as compared to the hCAIX and hCAXII with half of the maximal concentrations of 0.75 ± 0.13 μM, and 0.24 ± 0.18 μM, respectively. Moreover, the compounds 4k, 4j and 4g were docked inside the active pocket of the crystallographic structure of the isoforms hCAXII, hCAIX and hCAXII, respectively. The docked inhibitors showed the binding interactions with the important amino acid residues such as Leu1198, Thr1199, His1094, and Phe1131 in hCAXII isozyme; residues Val121, Thr200, Pro203, and Gln71 in hCAIX; the amino acids Val119, Leu197, Gln89, and Asn64 in the case of hCAXII. In addition, structural geometries, reactivity descriptors, optimization energy and electronic parameters were calculated to predict the activity of the synthesized compounds.

Topics & Concepts

Carbonic anhydraseAcetazolamidePyrazoleIsozymeChemistryEnzymeGene isoformDocking (animal)Amino acidStereochemistryIC50Carbonic Anhydrase IActive siteBenzeneBiochemistryIn vitroOrganic chemistryBiologyMedicinePhysiologyNursingGeneEnzyme function and inhibitionCholinesterase and Neurodegenerative DiseasesSynthesis and Catalytic Reactions
Synthesis, characterization and biological evaluation of pyrazole-based benzene sulfonamides as inhibitors of human carbonic anhydrase II, IX and XII | Litcius